Published in Mental Health Business Week, August 9th, 2008
"Food and Drug Administration (FDA) issued black box warnings for several atypical antipsychotics titled ''Cerebrovascular Adverse Events, Including Stroke, in Elderly Patients With Dementia.'' Subsequently, the FDA initiated a meta-analysis of safety data from 17 registration trials across 6 antipsychotic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.